Skip to main content
Top
Published in: Abdominal Radiology 3/2021

01-03-2021 | Classics in Abdominal Radiology

Spalding sign

Authors: Felipe Matsunaga, Sree Harsha Tirumani

Published in: Abdominal Radiology | Issue 3/2021

Login to get access

Excerpt

The Spalding sign, an eponym indicative of intrauterine fetal demise which refers to overlapping fetal cranial bones at the sutures, was first described by the obstetrician Alfred Baker Spalding in a case series in 1922 based on the radiographic appearance of these osseous structures [1]. In addition to the detection of gas within the heart and great vessels, it remained one of the few specific radiographic signs of fetal demise prior to the use of ultrasonography for the detection of fetal heart rate. Though initially a radiographic finding, the sign is still nevertheless visualized sonographically. …
Literature
1.
go back to reference Spalding, Alfred Baker. A pathognomonic sign of intra-uterine death. Surgery, Gynecology and Obstetrics. 1922;34:754. Spalding, Alfred Baker. A pathognomonic sign of intra-uterine death. Surgery, Gynecology and Obstetrics. 1922;34:754.
2.
go back to reference Townsend L. Obstetrics for students. [2d ed. Carlton, Victoria]: Melbourne University Press; 1969. 722 p. Townsend L. Obstetrics for students. [2d ed. Carlton, Victoria]: Melbourne University Press; 1969. 722 p.
Metadata
Title
Spalding sign
Authors
Felipe Matsunaga
Sree Harsha Tirumani
Publication date
01-03-2021
Publisher
Springer US
Published in
Abdominal Radiology / Issue 3/2021
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-020-02769-z

Other articles of this Issue 3/2021

Abdominal Radiology 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.